Valeritas (NSDQ:VLRX) said today that it began the process to register its wearable insulin delivery device, V-Go, in China.
The company noted that it signed an agreement with an unnamed contract research organization to work directly with the China National Drug Administration, in the hopes of winning regulatory approval for V-Go in China.
Get the full story at our sister site, Drug Delivery Business News.
The post Valeritas kicks off device registration process in China appeared first on MassDevice.